Evidence & regulatory context
- Mechanism
- Not recorded
- Target
- Not recorded
- Injury models
- Spinal cord injury
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
MouseSpinal cord injuryContusionC57Bl/6 recipients; donor bone marrow mesenchymal stem cells from male GFP transgenic C57Bl/6 micefemale recipients, male donor cellsn = Transmission electron microscopy at 28 days used 12 animals…intralesional injection directly into the injury epicentre using a Hamilton syringe and stereotaxic frame3 microlitres of cell suspension injected at 1 microlitre p…Immediately after spinal cord injury
Model: Moderate contusion spinal cord injury of approximately 70 kdyn applied with the Infinite Horizon Impactor after T10 dorsal laminectomy
BMMSC-IGF1 improved Basso Mouse Scale scores from week 2 to week 4 and normalised gait, increased donor cell survival and antioxidant gene expression, reduced MDA and nitrite and preserved myelin, whereas wild-type BMMSCs gave no significant functional gain and lesion volume did not differ between…
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.